Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS ...

Masimo’s long-running proxy fight has come to a close, at least for now. | Masimo’s long-running proxy fight has come to a ...

In a report released yesterday, Vik Chopra from Wells Fargo assigned a Buy rating to Masimo (MASI – Research Report), with a price target ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares opened today ...

Masimo, the company that forced Apple to remove the Blood Oxygen feature, has partnered with Google to improve Wear OS health ...

Masimo is partnering with Qualcomm Technologies to develop a comprehensive reference platform to expand the Wear OS by ...

Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of the core issues to consider in ...

Global medical innovator Masimo has announced a partnership with Google to develop a new reference platform for original ...

Google has now partnered with Masimo and Qualcomm to create health-focused Wear OS reference platforms, integrating Masimo's ...

"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...

The future of an iconic Orange County medtech entrepreneur – who was once compared to Steve Jobs – is at stake this week.

Founder Joe Kiani has led Masimo for 35 years. But he says he'll quit if he loses this week's proxy vote to Politan Capital.